Welcome!

Agile Computing Authors: Pat Romanski, Liz McMillan, Mamoon Yunus, Elizabeth White, Leon Adato

News Feed Item

Programme ARTERIA - L'Institut de Cardiologie de Montréal pilotera #ARTERIA : un programme de recherche d'envergure pour les patients atteints ou à risque d'une maladie cardiovasculaire

MONTRÉAL, February 14, 2014 /PRNewswire/ --



C'est en présence de la première ministre du Québec, Pauline Marois, accompagnée des ministres québécois Nicolas Marceau, Jean-François Lisée et Élaine Zakaïb, du maire de Montréal Denis Coderre et de représentants d'entreprises pharmaceutiques internationales que le docteur Jean-Claude Tardif, directeur du Centre de recherche de l'Institut de Cardiologie de Montréal (ICM), a rendu public aujourd'hui le programme de recherche ARTERIA visant la recherche de traitements novateurs dans la lutte contre les maladies cardiovasculaires, la première cause mondiale de décès. « Une fois de plus, l'Institut de Cardiologie de Montréal et son équipe de médecins, de chercheurs et de professionnels dédiés se démarquent comme leader mondial de la lutte contre les maladies cardiovasculaires. Ce programme aura des effets positifs et tangibles sur les patients atteints ou à risque de maladies cardiovasculaires », a déclaré le docteur Tardif.

Les voies de découvertes et d'innovation, qui sont rendues possibles grâce à ce programme unique, apporteront des bénéfices considérables aux patients à moyen et à long terme en venant transformer les pratiques médicales de traitement des maladies cardiovasculaires tout en se traduisant par des économies majeures pour le système de santé. ARTERIA permettra, entre autres, d'offrir une médecine de plus en plus personnalisée, de mieux soigner et de mieux médicamenter les patients et ainsi de sauver des vies. Rappelons que les maladies cardiovasculaires sont la principale cause d'hospitalisation et de décès sur la planète et plus de 1,3 million de personnes au pays en souffrent. Les maladies cardiovasculaires constituent également le fardeau le plus important dans les coûts de santé avec près de 22 G$ par année.

Un investissement majeur de 49,2 M$ grâce à un partenariat inédit

Ce projet novateur et d'envergure est rendu possible grâce à un montage financier de 49,2 M$, dont 18,2 M$ proviennent du gouvernement du Québec et 31 M$ d'investissements privés liés au secteur biopharmaceutique. « Nous sommes très fiers, au Centre de recherche de l'Institut de Cardiologie de Montréal, d'avoir réussi à réunir autour de ce programme de recherche des intervenants clés tels que le gouvernement du Québec, l'Université de Montréal et les entreprises pharmaceutiques les plus innovantes du monde, afin de mettre au service de nos patients et de l'ensemble des Québécois les fruits de cette importante recherche », a renchéri le docteur Tardif. ARTERIA entraînera aussi la création de 150 nouveaux emplois directs et hautement qualifiés.

Présents lors de l'annonce, les principaux partenaires privés ont tenu à saluer l'initiative du Centre de recherche de l'Institut de Cardiologie de Montréal au sujet de la mise sur pied de ce projet novateur, soulignant par le fait même le leadership incontestable de l'Institut sur la scène internationale.

« Par notre collaboration, nous sommes en mesure de combiner la recherche médicale et scientifique de portée mondiale de l'ICM avec nos capacités en médecine translationnelle et en développement clinique. C'est pourquoi pour Hoffmann-La Roche ltée, il ne fait aucun doute que l'Institut de Cardiologie de Montréal est une institution québécoise de classe mondiale », de mentionner le président-directeur général pour le Canada, M. Ronnie Miller.

Autre partenaire principal d'ARTERIA, Servier Canada inc., par le biais de son chef de la Direction au Canada, M. Frédéric Fasano a insisté sur la longue collaboration entre les deux entités : « Notre collaboration avec l'Institut de Cardiologie de Montréal a démarré il y a plus de 15 ans. Elle a été extrêmement productive en études et en innovations puisqu'un médicament traitant des malades d'insuffisance cardiaque a été largement façonné dans les murs de l'Institut. Travailler avec l'Institut de Cardiologie de Montréal, c'est côtoyer les médecins cardiologues et les chercheurs d'un des tout premiers centres de cardiologie en Amérique du Nord ».

Enfin, le partenaire MedImmune (filiale d'AstraZeneca) a tenu à souligner l'unicité de l'Institut de Cardiologie de Montréal et de son modèle. « En participant au programme ARTERIA, AstraZeneca, comme tous les partenaires publics et privés et tous les patients, bénéficiera de ce plateau technique exceptionnel dans le monde qu'est l'Institut de Cardiologie de Montréal. Seul l'Institut offre un modèle intégré allant de la génétique aux grandes études cliniques, en passant par la cellule. L'Institut de Cardiologie de Montréal est une institution unique en son genre dans le monde », a poursuivi la docteure Fouzia Laghrissi-Thode, vice-présidente mondiale responsable de la franchise cardiovasculaire et métabolique pour AstraZeneca à Londres.

Le Dr Guy Breton, recteur de l'Université de Montréal, à laquelle l'Institut de Cardiologie est affilié, s'est réjoui de l'annonce « Nous sommes très fiers des trois équipes de chercheurs de l'Université de Montréal qui ont reçu des subventions dans le cadre de ce nouveau programme. Je félicite tout particulièrement le Dr Tardif et son équipe de l'Institut de Cardiologie de Montréal qui mèneront un programme de recherche novateur à tous points de vue. En cette journée de la Saint-Valentin qui nous rappelle l'importance du cœur, je me réjouis de savoir que des chercheurs de très haut calibre auront accès aux ressources et aux partenaires qui leur permettront de développer de nouvelles avenues pour améliorer la santé cardiaque.

Étant le fruit d'un vaste partenariat diversifié, ARTERIA est aussi rendu possible par la contribution importante et l'appui tangible des autres partenaires suivants : Valeant Canada, Pharmascience inc., Thrasos Therapeutics inc., Pfizer Canada inc., Spartan Bioscience inc. et la Fondation de l'Institut de Cardiologie de Montréal.

Pour accéder à la galerie de photos : http://www.icm-mhi.org/fr/salle-presse/materiel-telecharger-et-contenu-multimedia/galerie-photos/conference-presse-projet-arteria

Fondé par le Dr Paul David, l'Institut de Cardiologie de Montréal célèbre en 2014 son 60e anniversaire. Cette année commémorative sera l'occasion de souligner les réalisations remarquables qui lui ont permis de se hisser parmi les plus grands centres de cardiologie au monde autant pour la qualité des soins aux patients, que pour la recherche, la prévention et l'enseignement. Montréalais par ses racines, international par sa renommée, l'Institut de Cardiologie de Montréal réunit depuis 60 ans des experts passionnés qui ont à cœur de repousser les limites de la médecine pour offrir des soins ultraspécialisés exceptionnels aux Québécois.

À propos de l'Institut de Cardiologie de Montréal : http://www.icm-mhi.org.

Facebook: facebook.com/institutcardiologiemontreal
Twitter: @ICMtl

Renseignements:
Vanessa Lyssan
+1-514-266-5434
[email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
There is only one world-class Cloud event on earth, and that is Cloud Expo – which returns to Silicon Valley for the 21st Cloud Expo at the Santa Clara Convention Center, October 31 - November 2, 2017. Every Global 2000 enterprise in the world is now integrating cloud computing in some form into its IT development and operations. Midsize and small businesses are also migrating to the cloud in increasing numbers. Companies are each developing their unique mix of cloud technologies and service...
SYS-CON Events announced today that Golden Gate University will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Since 1901, non-profit Golden Gate University (GGU) has been helping adults achieve their professional goals by providing high quality, practice-based undergraduate and graduate educational programs in law, taxation, business and related professions. Many of its courses are taug...
SYS-CON Events announced today that Grape Up will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company specializing in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the U.S. and Europe, Grape Up works with a variety of customers from emergi...
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
From 2013, NTT Communications has been providing cPaaS service, SkyWay. Its customer’s expectations for leveraging WebRTC technology are not only typical real-time communication use cases such as Web conference, remote education, but also IoT use cases such as remote camera monitoring, smart-glass, and robotic. Because of this, NTT Communications has numerous IoT business use-cases that its customers are developing on top of PaaS. WebRTC will lead IoT businesses to be more innovative and address...
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
SYS-CON Events announced today that Secure Channels, a cybersecurity firm, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Secure Channels, Inc. offers several products and solutions to its many clients, helping them protect critical data from being compromised and access to computer networks from the unauthorized. The company develops comprehensive data encryption security strategie...
An increasing number of companies are creating products that combine data with analytical capabilities. Running interactive queries on Big Data requires complex architectures to store and query data effectively, typically involving data streams, an choosing efficient file format/database and multiple independent systems that are tied together through custom-engineered pipelines. In his session at @BigDataExpo at @ThingsExpo, Tomer Levi, a senior software engineer at Intel’s Advanced Analytics ...
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, will introduce two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a...
SYS-CON Events announced today that App2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. App2Cloud is an online Platform, specializing in migrating legacy applications to any Cloud Providers (AWS, Azure, Google Cloud).
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Consumers increasingly expect their electronic "things" to be connected to smart phones, tablets and the Internet. When that thing happens to be a medical device, the risks and benefits of connectivity must be carefully weighed. Once the decision is made that connecting the device is beneficial, medical device manufacturers must design their products to maintain patient safety and prevent compromised personal health information in the face of cybersecurity threats. In his session at @ThingsExpo...
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.